Cost-effectiveness analysis of trastuzumab emtansine (T-DM1) in treating HER-2 positive advanced breast cancer in Taiwan. Wang LC, Kuo CN, Ko Y. Breast J 2020 Sep 17. doi: 10.1111/tbj.14053.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang LC, Kuo CN, Ko Y. Cost-effectiveness analysis of trastuzumab emtansine (T-DM1) in treating HER-2 positive advanced breast cancer in Taiwan. Breast J 2020 Sep 17. doi: 10.1111/tbj.14053.
PMID: 32945063